-
-
-
-
-
-
-
Sonoma Pharmaceuticals appoints new board member and executive
-
-
-
-
-
-
-
Wolfe Research Downgrades Avidity Biosciences (RNA) to Peerperform
-
-
-
-
-
-
-
H.C. Wainwright Downgrades Avidity Biosciences (RNA) to Neutral Post Novartis Acquisition
-
-
-
-
-
-
-
Avidity Biosciences (RNA) PT Raised to $87 at H.C. Wainwright
-
-
-
-
-
-
-
Novartis (NVS) Made A Takeover Approach Avidity Biosciences (RNA) - FT
-
-
-
-
-
-
-
Avidity Biosciences (RNA) PT Raised to $54 at BofA Securities
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Avidity Biosciences (RNA)
-
418,741 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

